logo
Share SHARE
FONT-SIZE Plus   Neg

Novartis Announces Agreement With FDA On Label Changes For Gilenya - Quick Facts

Novartis (NVS: Quote) said it agreed with the US Food and Drug Administration on label changes for Gilenya, or fingolimod.

The update to the Gilenya prescribing information includes patient selection parameters to aid in the identification of candidates for Gilenya treatment and more specific recommendations for treatment initiation for patients with relapsing forms of MS in the United States. The company noted that the update marks the conclusion of discussions initiated in December 2011.

The updated FDA label for Gilenya indicates that all patients initiating treatment with Gilenya should have an electrocardiogram prior to the first dose of the medicine and after the six-hour first-dose observation period in addition to hourly measurement of blood pressure and heart rate. Additionally, specific initiation guidance for patients is now provided to better aid healthcare providers. Further, there are revised recommendations on how to re-initiate therapy should Gilenya be interrupted.

If therapy is interrupted for patients who are already taking Gilenya, they should undergo the new recommended monitoring upon treatment re-initiation as per the revised recommendations on the duration of interruption depending on duration of prior treatment.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Ride-sharing service Uber Technologies Inc. is facing a lawsuit filed by the National Federation of the Blind of California alleging discrimination of blind people. According to the lawsuit, Uber drivers' discriminate blind persons by refusing to transport their guide dogs along with them. The lawsuit... Video game publisher Activision Blizzard has officially unveiled Call of Duty: Black Ops III, after some teases and a trailer as well. The game will be shipped starting November 6, and will be available on Xbox One, PS4, and PC. If calories are not reduced, exercise alone can have no effect on obesity, says British Sports Medicine, a peer-reviewed journal of sport and exercise medicine. The journal says the blame for expanding waist lines is directly on the type and amount of calories consumed and the poor diet generates more disease than physical inactivity, alcohol and smoking combined.
comments powered by Disqus
Follow RTT